| HOME >> MEDICINE >> TECHNOLOGY |
97 YPSOMED - TOTAL REVENUES & R&D EXPENSES ($MILLION)
98 YPSOMED - TOTAL REVENUES BY SEGMENT ($MILLION)
99 ANTARES PHARMA - TOTAL REVENUES & R&D EXPENDITURE ($MILLION)
100 ANTARES PHARMA - TOTAL REVENUES, BY GEOGRAPHY ($MILLION)
101 QLT – TOTAL REVENUES & R&D EXPENSES ($MILLION)
102 QLT – TOTAL REVENUES, BY GEOGRAPHY ($MILLION)
103 NEKTAR - TOTAL REVENUES & R&D EXPENSES ($MILLION)
104 NEKTAR – TOTAL REVENUES, BY GEOGRAPHY ($MILLION)
LIST OF FIGURES
1 INJECTABLE DRUG DELIVERY DEVICES MARKET (2010 – 2015)
2 INJECTABLE DRUG DELIVERY FORMULATION MARKET (2010 – 2015)
3 INJECTABLE DRUG DELIVERY DEVICES MARKET (2009)
4 DRUG DELIVERY TECHNOLOGY BY ROUTE OF ADMINISTRATION (2009)
5 GLOBAL BIOLOGIC DRUG SALES (2004 – 2015)
6 GLOBAL BIOLOGICS DRUG SALES BY ROUTE OF DRUG ADMINISTRATION (2010)
7 INJECTABLE DRUG DELIVERY DEVICES MARKET SCENARIO (2009)
8 PRODUCT LIFE CYCLE OPTIONS FOR PHARMACEUTICAL COMPANIES
9 IMPACT OF KEY MARKET DRIVERS AND RESTRAINTS
10 MARKET SHARE OF MAJOR PLAYERS
11 FACTORS AFFECTING SELECTION OF INJECTABLE DEVICE
12 SIZE OF NANOPARTICLES AND TARGET SITES FOR DRUG DELIVERY
13 DRUG DELIVERY FORMULATION MARKET SCENARIO
14 GLOBAL DRUG SALES BY ROUTE OF ADMINISTRATION (2009)
15 INDUSTRY GROWTH STRATEGIES (2008 – 2010)
To order this report:
: Global Injectable Drug Delivery Market (2010 - 2015)
Check our Company Profile, SWOT and Revenue Analysis!
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |